Nakajima K et al. |
Effects of 15-deoxyspergualin and FK506 on the histology and survival of hamster-to-rat cardiac xenotransplantation. |
1989 |
Transplant. Proc. |
pmid:2468223
|
Ochiai T et al. |
Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine. |
1989 |
Transplant. Proc. |
pmid:2468228
|
Yasunami Y et al. |
Effects of a novel immunosuppressive agent, FK-506, on islet allograft survival in the rat. |
1989 |
Transplant. Proc. |
pmid:2468234
|
Kobayashi C et al. |
Suppression of corneal graft rejection in rabbits by a new immunosuppressive agent, FK-506. |
1989 |
Transplant. Proc. |
pmid:2468254
|
Kuroki H et al. |
Experimental studies of vascularized allogeneic limb transplantation in the rat using a new immunosuppressive agent, FK-506: morphological and immunological analysis. |
1989 |
Transplant. Proc. |
pmid:2468255
|
Arai K et al. |
Prolonged limb allograft survival with short-term treatment with FK-506 in rats. |
1989 |
Transplant. Proc. |
pmid:2468256
|
Ishibashi M et al. |
Immunopharmacologic effects of immunosuppressive agents explored by a new effector monocyte generation assay. |
1989 |
Transplant. Proc. |
pmid:2469228
|
Starzl TE et al. |
Liver transplantation: an unfinished product. |
1989 |
Transplant. Proc. |
pmid:2469232
|
Hatanaka H et al. |
FK-506 related compounds produced by Streptomyces tsukubaensis No. 9993. |
1989 |
J. Antibiot. |
pmid:2470720
|
Gschwendt M et al. |
The immunosuppressant FK-506, like cyclosporins and didemnin B, inhibits calmodulin-dependent phosphorylation of the elongation factor 2 in vitro and biological effects of the phorbol ester TPA on mouse skin in vivo. |
1989 |
Immunobiology |
pmid:2471685
|
Fujii Y et al. |
Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes. |
1989 |
Transplantation |
pmid:2472025
|
Walliser P et al. |
Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506. |
1989 |
Immunology |
pmid:2480331
|
Aoki M et al. |
[Histological observations of immunosuppressive effects of FK-506 in canine lung allotransplantation]. |
1989 |
Bull Chest Dis Res Inst Kyoto Univ |
pmid:2482787
|
Kay JE and Benzie CR |
T lymphocyte activation through the C28 pathway is insensitive to inhibition by the immunosuppressive drug FK-506. |
1989 |
Immunol. Lett. |
pmid:2483716
|
Leonard DK et al. |
Toxicity of FK-506 in human fetal pancreas. |
1989 |
Diabetes |
pmid:2463195
|
Stephen M et al. |
Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine. |
1989 |
Transplantation |
pmid:2463701
|
McCauley J et al. |
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. |
1989 Dec 23-30 |
Lancet |
pmid:2481200
|
Collier SJ |
Immunosuppressive drugs. |
1989-1990 |
Curr. Opin. Immunol. |
pmid:2484794
|
Murase N et al. |
Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689906
|
Mattila PS et al. |
The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. |
1990 |
EMBO J. |
pmid:1702384
|